menu toggle

February 16, 2023

InnomarLive 2023: Emerging trends in the oncology ecosystem

Toronto Congress Centre, 650 Dixon Road | Toronto, ON

Turning today’s challenges into opportunities for patient care and access

We are excited to welcome you live and in-person to our InnomarLive 2023 conference series.

Conference Series:

Join us to learn and engage in conversation around the impact of emerging changes in the oncology landscape and the effect on drug approvals, reimbursement, and patient care.

Conference highlights:

Join us on Thursday, February 16, 8:00 am – 3:30 pm

  • How stakeholders are addressing the increasing volume of new oncology treatments 
  • The challenges faced by payers in the evaluation of new therapies
  • Delivering quality care in a resource-constrained environment: The oncologist perspective
  • Seeking diagnosis and treatment: The patient perspective
  • The promise of new cancer therapies, balanced with the need for drug plan sustainability 
  • The potential role of RWE in the evaluation of new oncology drugs

You should attend if you work in:

  • Market Access / Reimbursement 
  • Regulatory Affairs 
  • Marketing / Market Research 
  • Stakeholder Relations / Government Affairs 
  • New Product Launches / Drug Commercialization 
  • Drug Plan Management - Public and Private Payers 

Guest speakers include:

  • Melissa Hunt, Director, Bureau of Metabolism, Oncology and Reproductive Sciences, Pharmaceutical Drugs Directorate, Health Canada
  • Brent Fraser, Vice President, Pharmaceutical Reviews, CADTH
  • Sylvie Bouchard, Director, Drug Evaluation and Technologies for Reimbursement Directorate, INESSS
  • Daniel Sperber, Senior Economist, pan-Canadian Pharmaceutical Alliance (pCPA)
  • Daria O’Reilly, Lead Health Economist, Pharmacy Consulting Health Benefits and Payment Solutions, TELUS Health
  • Durhane Wong-Rieger, President and CEO, CORD
  • Carlene Todd, Vice President, Access, Hoffmann-La Roche Limited
  • Dr. Gerald Batist, Director, Dept. of Oncology, Sir Mortimer B. Davis-Jewish General Hospital;
    Director, McGill University Centre for Translational Research in Cancer Professor, Department of Oncology, McGill University
  • Claire Edmonds, Registered Psychotherapist, affiliated with Wellspring
  • Shirley Chen, Medication Reimbursement Specialist, Princess Margaret Cancer Centre
  • Dale Hanna, Director, Cell and Gene Therapy Solutions, AmerisourceBergen
  • Nicole Mittmann, Vice-President, Scientific Evidence, Methodologies, and Resources, CADTH
  • Sandra Anderson, SVP International Commercialization, Amerisource Bergen

Pricing (per attendee) – Full day conference:

$750 – 1 attendee
$700 – 2-5 attendees
$650 – 5 – 7 attendees
$600 – 8+ attendees

Reserve your spot and register today!

To register, please click the email address below and provide; organization name, attendee names and titles, and payment preference (credit card or invoice).

Please note, this is an English only event with no virtual option.

*Please note: You may use a credit card or choose to be invoiced by Innomar Strategies. 

InnomarLive 2020 - Patient Support Programs: Today, Tomorrow and the Future

12/14/2020 12:00:00 PM - 12/17/2020 1:00:00 PM

Life Sciences Ontario - Annual Policy Forum

11/2/2020 9:00:00 AM - 11/6/2020 2:00:00 PM

Webinar: 2020 pCODR Updates

9/9/2020 12:00:00 PM - 9/9/2020 1:00:00 PM